A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)

PHASE2CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Repeated IVF Failure
Interventions
DRUG

NT100

DRUG

Placebo

Trial Locations (21)

10032

Columbia University, New York

19010

Main Line Fertility Center, Bryn Mawr

19713

Reproductive Associates of Delaware, Newark

20037

Columbia Fertility Associates, Washington D.C.

20850

Shady Grove Fertility, Rockville

30342

Georgia Reproductive Specialists, Atlanta

33176

IVF and Fertility Center of Miami, Miami

33759

Florida Fertility Institute, Clearwater

45209

Institute for Reproductive Health, Cincinnati

60035

Fertility Centers of Illinois / Highland Park IVF Center, Highland Park

60610

Fertility Centers of Illinois / River North IVF Center, Chicago

76022

Center for Assisted Reproduction, Bedford

77063

Houston Fertility Institute, Houston

77598

Center of Reproductive Medicine, Webster

84062

Utah Fertility Center, Pleasant Grove

91105

HRC Fertility, Pasadena

91436

HRC Fertility, Encino

92663

HRC Fertility, Newport Beach

Unknown

UCSF, San Francisco

Boston IVF, Waltham

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Nora Therapeutics, Inc.

INDUSTRY

NCT01864356 - A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF) | Biotech Hunter | Biotech Hunter